Opioids and PACE
A recent OIG report expresses concerns about the high proportion of Part D beneficiaries receiving prescription opioids. This is one of many reasons that both state and federal governments are making changes to prescribing regulations. CareKinesis will be hosting two webinars in May to discuss opioids and PACE. This webinar will review regulatory perspectives for PACE.
Presenter: Richard B. Greene, PharmD, MBA, Sr. Director of Regulatory Affairs